Healthcare provider profile · identity verified

Rajesh V Patel, MD

Internal Medicine · HOLIDAY, FL · NPI 1770531899

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	488	129
Amlodipine Besylate	Amlodipine Besylate	476	130
Losartan Potassium	Losartan Potassium	380	105
Metformin Hcl	Metformin Hcl	317	86
Levothyroxine Sodium	Levothyroxine Sodium	316	82
Rosuvastatin Calcium	Rosuvastatin Calcium	309	89
Lisinopril	Lisinopril	307	84
Simvastatin	Simvastatin	251	71
Albuterol Sulfate Hfa	Albuterol Sulfate	243	55
Glimepiride	Glimepiride	242	69
Prednisone	Prednisone	215	118
Clopidogrel	Clopidogrel Bisulfate	189	54
Tamsulosin Hcl	Tamsulosin Hcl	168	50
Trazodone Hcl	Trazodone Hcl	160	43
Omeprazole	Omeprazole	158	48
Metoprolol Tartrate	Metoprolol Tartrate	136	41
Alendronate Sodium	Alendronate Sodium	129	44
Carvedilol	Carvedilol	124	37
Tramadol Hcl	Tramadol Hcl	122	36
Eliquis	Apixaban	107	25
Alprazolam	Alprazolam	104	21
Metoprolol Succinate	Metoprolol Succinate	103	29
Famotidine	Famotidine	99	38
Furosemide	Furosemide	98	34
Citalopram Hbr	Citalopram Hydrobromide	93	30
Hydrochlorothiazide	Hydrochlorothiazide	84	24
Atenolol	Atenolol	80	19
Pravastatin Sodium	Pravastatin Sodium	80	21
Escitalopram Oxalate	Escitalopram Oxalate	75	22
Azithromycin	Azithromycin	72	60
Finasteride	Finasteride	71	23
Gabapentin	Gabapentin	70	23
Fluticasone Propionate	Fluticasone Propionate	69	25
Sertraline Hcl	Sertraline Hcl	69	15
Duloxetine Hcl	Duloxetine Hcl	62	16
Baclofen	Baclofen	61	34
Metformin Hcl Er	Metformin Hcl	59	26
Pioglitazone Hcl	Pioglitazone Hcl	58	17
Pantoprazole Sodium	Pantoprazole Sodium	56	24
Potassium Chloride	Potassium Chloride	56	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	56	19
Bumetanide	Bumetanide	52	15
Meloxicam	Meloxicam	52	27
Spironolactone	Spironolactone	48	20
Triamcinolone Acetonide	Triamcinolone Acetonide	48	27
Ezetimibe	Ezetimibe	47	13
Mirtazapine	Mirtazapine	47	11
Cefuroxime	Cefuroxime Axetil	45	42
Clonazepam	Clonazepam	42	11
Symbicort	Budesonide/Formoterol Fumarate	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	12
Allopurinol	Allopurinol	37	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Solifenacin Succinate	Solifenacin Succinate	37	13
Glipizide	Glipizide	34	suppressed
Nitroglycerin	Nitroglycerin	32	17
Memantine Hcl	Memantine Hcl	31	11
Montelukast Sodium	Montelukast Sodium	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	24	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	13
Irbesartan	Irbesartan	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Metolazone	Metolazone	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Levofloxacin	Levofloxacin	16	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Ozempic	Semaglutide	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Novolin R	Insulin Regular, Human	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Novolin N	Insulin Nph Human Isophane	13	suppressed
Primidone	Primidone	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Topiramate	Topiramate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error